Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-06-04 @ 4:05 AM
Study NCT ID:
NCT05347394
Status:
COMPLETED
Last Update Posted:
2023-05-15
First Post:
2022-04-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 1 Dose Escalation Study of Oral VX-708 in Healthy Participants
Sponsor:
Vertex Pharmaceuticals Incorporated
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VX21-708-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None